Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Funct Plant Biol ; 512024 04.
Article in English | MEDLINE | ID: mdl-38683936

ABSTRACT

Effective identification and usage of genetic variation are prerequisites for developing nutrient-efficient cultivars. A collection of 94 safflower (Carthamus tinctorius ) genotypes (G) was investigated for important morphological and photosynthetic traits at four nitrogen (N) treatments. We found significant variation for all the studied traits except chlorophyll b (chl b ) among safflower genotypes, nitrogen treatments and G×N interaction. The examined traits showed a 2.82-50.00% increase in response to N application. Biological yield (BY) reflected a significantly positive correlation with fresh shoot weight (FSW), root length (RL), fresh root weight (FRW) and number of leaves (NOL), while a significantly positive correlation was also observed among carotenoids (C), chlorophyll a (chl a ), chl b and total chlorophyll content (CT) under all treatments. Superior genotypes with respect to plant height (PH), FSW, NOL, RL, FRW and BY were clustered into Group 3, while genotypes with better mean performance regarding chl a , chl b C and CT were clustered into Group 2 as observed in principal component analysis. The identified eight best-performing genotypes could be useful to develop improved nitrogen efficient cultivars. Genome-wide association analysis resulted in 32 marker-trait associations (MTAs) under four treatments. Markers namely DArT-45481731 , DArT-17812864 , DArT-15670279 and DArT-45482737 were found consistent. Protein-protein interaction networks of loci associated with MTAs were related to fatty acid and branched-chain amino acid metabolism and histone modifications.


Subject(s)
Amino Acids, Branched-Chain , Carthamus tinctorius , Fatty Acids , Genome-Wide Association Study , Nitrogen , Carthamus tinctorius/genetics , Carthamus tinctorius/metabolism , Carthamus tinctorius/drug effects , Nitrogen/metabolism , Fatty Acids/metabolism , Amino Acids, Branched-Chain/metabolism , Genotype , Histone Code/drug effects , Chlorophyll/metabolism , Genetic Loci
2.
Plants (Basel) ; 9(5)2020 May 21.
Article in English | MEDLINE | ID: mdl-32455816

ABSTRACT

Safflower is an important oilseed crop mainly grown in the arid and semi-arid regions of the world. The aim of this study was to explore phenotypic and genetic diversity, population structure, and marker-trait association for 100-seed weight in 94 safflower accessions originating from 26 countries using silicoDArT markers. Analysis of variance revealed statistically significant genotypic effects (p < 0.01), while Turkey samples resulted in higher 100-seed weight compared to Pakistan samples. A Constellation plot divided the studied germplasm into two populations on the basis of their 100-seed weight. Various mean genetic diversity parameters including observed number of alleles (1.99), effective number of alleles (1.54), Shannon's information index (0.48), expected heterozygosity (0.32), and unbiased expected heterozygosity (0.32) for the entire population exhibited sufficient genetic diversity using 12232 silicoDArT markers. Analysis of molecular variance (AMOVA) revealed that most of the variations (91%) in world safflower panel are due to differences within country groups. A model-based structure grouped the 94 safflower accessions into populations A, B, C and an admixture population upon membership coefficient. Neighbor joining analysis grouped the safflower accessions into two populations (A and B). Principal coordinate analysis (PCoA) also clustered the safflower accessions on the basis of geographical origin. Three accessions; Egypt-5, Egypt-2, and India-2 revealed the highest genetic distance and hence might be recommended as candidate parental lines for safflower breeding programs. The mixed linear model i.e., the Q + K model, demonstrated that two DArTseq markers (DArT-45483051 and DArT-15672391) had significant association (p < 0.01) for 100-seed weight. We envisage that identified DArTseq markers associated with 100-seed weight will be helpful to develop high-yielding cultivars of safflower through marker-assisted breeding in the near future.

3.
Int Urol Nephrol ; 51(2): 343-349, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30515731

ABSTRACT

PURPOSE: Living with end-stage renal disease may be burdensome, not only for patients, but also for caregivers. In this study, we aim to compare caregiver burden, psychological symptoms in caregivers of peritoneal dialysis (PD), hemodialysis (HD), and transplantation (TX), and find out associated factors. METHODS: A total of 43 PD, 42 HD, 42 TX patients and a total of 127 caregivers that were actively involved with the care of their patients' dialysis were enrolled. Patients had been on renal replacement therapy at least for 6 months and caregivers had given care at least for 6 months. The World Health Organization Quality of Life short version and hospital anxiety and depression scale (HAD) were applied to the patients. Symptom Checklist-90-Revised and Zarit caregiver burden scale were applied to the caregivers. RESULTS: Zarit caregiver burden score was found highest in HD group, which was significantly higher than PD and TX. All three groups had similar HAD anxiety scores, whereas the HAD depression score was highest in HD group, lower in PD, and lowest in TX. Quality of life was lowest in HD group. Zarit caregiver burden score was found higher in caregivers with symptoms like somatization, anxiety, obsessive-compulsive, depression, interpersonal sensitivity, psychoticism, paranoid ideation, hostility, and additional psychological symptoms than the ones who did not have these symptoms. Psychological symptoms were similar in PD, HD, and TX groups. CONCLUSION: Caregiver burden was found highest in HD group. Educational, social, and psychological support interventions may be considered for caregivers.


Subject(s)
Behavioral Symptoms , Caregivers/psychology , Compassion Fatigue , Cost of Illness , Kidney Failure, Chronic , Quality of Life , Adaptation, Psychological/physiology , Adult , Behavioral Symptoms/diagnosis , Behavioral Symptoms/prevention & control , Behavioral Symptoms/psychology , Compassion Fatigue/etiology , Compassion Fatigue/prevention & control , Compassion Fatigue/psychology , Female , Humans , Kidney Failure, Chronic/psychology , Kidney Failure, Chronic/therapy , Kidney Transplantation/psychology , Male , Middle Aged , Needs Assessment , Peritoneal Dialysis/psychology , Renal Dialysis/psychology , Turkey/epidemiology
4.
Turkiye Parazitol Derg ; 38(2): 91-6, 2014 Jun.
Article in Turkish | MEDLINE | ID: mdl-25016114

ABSTRACT

OBJECTIVE: This study was conducted to identify the seroprevalance of diseases which are zoonotic and responsible from abortion such as toxoplasmosis, listeriosis and brucellosis in Holstein crossbred cattle of different age and sex in Adana province, between 2008 April-September. METHODS: For this purpose, blood serum samples were collected from 132 cattle and analyzed for Toxoplasma gondii, Listeria monocytogenes and Brucella abortus antibodies. T. gondii, L. monocytogenes and Brucella abortus antibodies were determined by the standard Sabin- Feldman Dye Test (SFDT), Osebold method and Microtube Agglutination Test (MAT) respectively, from the blood serum samples. RESULTS: 132 serum tested 56.06% samples of T. gondii, 40.9% and 3.03% of L. monocytogenes and defined the B.abortus antibodies were found to be seropositive terms. There were no statistically significant difference between seropositive T. gondii, L. monocytogenes and B.abortus antibodies among age groups (p>0.05). CONCLUSION: In this study, for the first time in cattle in the region of Adana serological methods revealed the presence L. monocytogenes, toxoplasmosis and listeriosis were higher than brucellosis seropositivity. Moreover, the prevalence of these diseases in the same animal at the highest rate was determined for T. gondii and L. monocytogenes.


Subject(s)
Antibodies, Protozoan/blood , Brucellosis/epidemiology , Listeriosis/epidemiology , Toxoplasmosis, Animal/epidemiology , Animals , Antibodies, Bacterial/blood , Brucella abortus/immunology , Brucellosis/blood , Brucellosis/immunology , Cattle , Coinfection , Female , Humans , Listeria monocytogenes/immunology , Listeriosis/blood , Listeriosis/immunology , Male , Pregnancy , Seroepidemiologic Studies , Toxoplasma/immunology , Toxoplasmosis, Animal/blood , Toxoplasmosis, Animal/immunology , Turkey/epidemiology
5.
Ren Fail ; 32(4): 455-8, 2010 May.
Article in English | MEDLINE | ID: mdl-20446783

ABSTRACT

UNLABELLED: In large patient populations, it has been established that calculated (c) and measured (m) plasma levels of low-density lipoprotein cholesterol (LDL-C) were comparable, but this issue is not known to be tested in renal transplant recipients (RTRs). Herein we aimed to compare the plasma levels of LDL-C that was calculated by Friedewald formula (FF) and direct measurement in RTRs. METHODS: LDL-C was measured by direct method and by FF in 193 fasting venous blood samples obtained from 103 RTRs. Patients had triglyceride (TG) levels <400 mg/dL. Patients were treated with prednisolone, calcineurin inhibitors (CNIs), and/or sirolimus and everolimus. RESULTS: The mean plasma levels of LDL-C for calculated and direct measurement were 100.81 +/- 32.79 mg/dL and 107.82 +/- 33.23 mg/dL, respectively (p < 0.01). The differences between cLDL-C and mLDL-C were similar according to usage of angiotensin receptor blockers (ARB)/angiotensin-converting enzyme inhibitors (ACEI), CNI, or mammalian target of rapamycin inhibitor (mTOR), tacrolimus or cyclosporine, and serum creatinine levels. mLDL-C and cLDL (FF) were highly correlated (r = 0.977). The mLDL-C level was calculated by following formula: LDL-C = 8.018 + (0.99 x FF cLDL-C) and the mean difference was 0 for last formula. CONCLUSION: The LDL-C can be calculated by the following formula: LDL-C = 8.018 + (0.99 x FF LDL-C). The coefficient of determination correlation (r) for this regression was 0.977, which indicates that the calculated LDL-C levels can be used in RTRs with TG lower than 400 mg/dL. mLDL-C was significantly higher than cLDL-C. We observed that difference between cLDL-C and mLDL-C levels were not affected by serum creatinine levels and usage of CNIs, sirolimus, everolimus, ACEI, and ARB in RTRs.


Subject(s)
Cholesterol, LDL/blood , Kidney Transplantation , Adult , Creatinine/blood , Female , Humans , Immunosuppressive Agents/therapeutic use , Male , Regression Analysis
6.
Int Urol Nephrol ; 41(1): 145-52, 2009.
Article in English | MEDLINE | ID: mdl-18766457

ABSTRACT

BACKGROUND: Mycophenolate mofetil (MMF) has shown to be a reliable choice in the treatment of glomerulonephritis. We retrospectively reviewed the clinical course and response to MMF therapy in 49 patients with primary glomerulopathy (37 patients) and lupus nephritis [class III (five patients) and IV (seven patients)]. METHODS: Patients were treated with MMF for more than 6 months as a primary (18 patients) or an adjunctive treatment (31 patients). Patients were also on methylprednisolone (2-20 mg/day) and angiotensin converting enzyme inhibitor/angiotensin receptor blocker. RESULTS: The mean age of the patient cohort was 33.69 +/- 12.4 years (range 19-59 years). Twenty-four-hour urinary protein excretion was reduced from 3.50 +/- 3.08 g prior to the commencement of MMF drug therapy to 1.21 +/- 1.44 and 0.99 +/- 1.34 g at the sixth and 12th months of MMF therapy, respectively (P < 0.05 for all). During this same period, significant increases in serum total protein (from 5.92 +/- 1.38 to 6.59 +/- 0.79 and 6.81 +/- 0.77 g/dl) and albumin levels (from 3.23 +/- 1.10 to 3.93 +/- 0.67 and 4.21 +/- 0.50 g/dl) were detected, whereas total cholesterol and low-density lipoprotein levels were found to be significantly decreased (P < 0.05 for all). Serum creatinine levels did not significantly change. The efficacy of MMF in reducing proteinuria was similar in both first line and an adjunctive therapy. The efficacy of MMF therapy began at the third month of treatment and continued through to the 12th month. CONCLUSION: Mycophenolate mofetil therapy was found to be useful in achieving improvements in proteinuria and nephrotic syndrome and stabilizing renal function. It was also a well-tolerated drug by the majority of the patients. Based on our results, we suggest that MMF may be alternative therapy for resistant/relapsing primary glomerulopathies and lupus nephritis.


Subject(s)
Glomerulonephritis/drug therapy , Immunosuppressive Agents/therapeutic use , Lupus Nephritis/drug therapy , Mycophenolic Acid/analogs & derivatives , Adult , Female , Humans , Male , Middle Aged , Mycophenolic Acid/therapeutic use , Retrospective Studies , Young Adult
7.
J Ren Nutr ; 16(3): 229-32, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16825025

ABSTRACT

It is well known that secondary hyperparathyroidism may be an extremely severe condition in chronic renal failure, and almost all patients with chronic kidney disease, even in the well-developed countries, encounter every kind of bone abnormalities if they are not treated properly. Although some sporadic cases have been reported of unique facial bone changes, the largest collection of this phenomenon has been reported by Sagliker et al. We also have found 6 of 9 patients who have these changes (Sagliker syndrome) to manifest class II malocclusion of the upper and lower jaws according to dental universally accepted criteria by performing cephalometric studies, x-ray plain films, tomographic procedures, and drawing technology.


Subject(s)
Bone Diseases/etiology , Cephalometry , Facial Bones , Hyperparathyroidism, Secondary/complications , Kidney Failure, Chronic/complications , Adolescent , Adult , Female , Humans , Male , Malocclusion, Angle Class II/diagnosis , Malocclusion, Angle Class II/epidemiology , Syndrome
8.
J Ren Nutr ; 16(3): 233-6, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16825026

ABSTRACT

Patients with chronic renal failure (CRF) often have signs and symptoms related to fluid and electrolyte disturbances, anemia, malnutrition, bone disease, and gastrointestinal problems. Vascular and neurologic impairment in particular remain an important source of morbidity and mortality in this vulnerable patient population. Sagliker syndrome is a novel syndrome that was recently described in 2004 in patients with CRF and severe and late secondary hyperparathyroidism who suffered from severe skull and facial bone changes, particularly from uglifying human face appearances and neuropsychiatric disorders. The goal of this study was to assess neuropsychiatric manifestations occurring in CRF patients with Sagliker syndrome. Four female and 8 male patients with CRF on regular dialysis at the hemodialysis units of the Internal Medicine Departments around southern Turkey participated in the study. All patients underwent a clinical neurologic examination performed by the same neurologist. Neuropsychiatric signs and symptoms were found in all cases. The results showed that the most frequent neurologic manifestations in CRF patients with Sagliker syndrome were headache, polyneuropathy, cranial neuropathy, fatigue, and psychiatric disorders.


Subject(s)
Bone Diseases/complications , Facial Bones , Hyperparathyroidism, Secondary/complications , Kidney Failure, Chronic/complications , Nervous System Diseases/epidemiology , Adolescent , Adult , Cranial Nerve Diseases/epidemiology , Fatigue , Female , Headache/epidemiology , Humans , Kidney Failure, Chronic/therapy , Male , Mental Disorders/epidemiology , Nervous System Diseases/complications , Nervous System Diseases/diagnosis , Polyneuropathies/epidemiology , Renal Dialysis , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...